prikaz prve stranice dokumenta Perioperative substitution testosterone therapy in patients with advanced head and neck squamous cell carcinoma
Pristup korisnicima matične ustanove
Znanstveni rad - Izvorni znanstveni rad
Perioperative substitution testosterone therapy in patients with advanced head and neck squamous cell carcinoma
Critical Reviews in Oncology/Hematology, 188 (2023); 104062. https://doi.org/10.1016/j.critrevonc.2023.104062
Manestar, Dubravko; Malvić, Goran; Velepič, Marko; Vukelić, Jelena; Vrebac, Ilinko; Tudor, Filip; Vukelić, Ivan; Braut, Tamara

Citirajte ovaj rad

Manestar, D., Malvić, G., Velepič, M., Vukelić, J., Vrebac, I., Tudor, F. ... Braut, T. (2023). Perioperative substitution testosterone therapy in patients with advanced head and neck squamous cell carcinoma. Critical Reviews in Oncology/Hematology, 188.. doi: 10.1016/j.critrevonc.2023.104062

Manestar, Dubravko, et al. "Perioperative substitution testosterone therapy in patients with advanced head and neck squamous cell carcinoma." Critical Reviews in Oncology/Hematology, vol. 188, 2023. https://doi.org/10.1016/j.critrevonc.2023.104062

Manestar, Dubravko, Goran Malvić, Marko Velepič, Jelena Vukelić, Ilinko Vrebac, Filip Tudor, Ivan Vukelić i Tamara Braut. "Perioperative substitution testosterone therapy in patients with advanced head and neck squamous cell carcinoma." Critical Reviews in Oncology/Hematology 188 (2023). https://doi.org/10.1016/j.critrevonc.2023.104062

Manestar, D., et al. (2023) 'Perioperative substitution testosterone therapy in patients with advanced head and neck squamous cell carcinoma', Critical Reviews in Oncology/Hematology, 188. doi: 10.1016/j.critrevonc.2023.104062

Manestar D, Malvić G, Velepič M, Vukelić J, Vrebac I, Tudor F, i sur.. Perioperative substitution testosterone therapy in patients with advanced head and neck squamous cell carcinoma. Critical Reviews in Oncology/Hematology [Internet]. 28.06.2023. [pristupljeno 04.05.2024.];188. doi: 10.1016/j.critrevonc.2023.104062

D. Manestar, et al., "Perioperative substitution testosterone therapy in patients with advanced head and neck squamous cell carcinoma", Critical Reviews in Oncology/Hematology, vol. 188, Lipanj 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:093127. [Citirano: 04.05.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:093127
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Perioperative substitution testosterone therapy in patients with advanced head and neck squamous cell carcinoma
AutorDubravko Manestar
AutorGoran Malvić
AutorMarko Velepič
AutorJelena Vukelić
AutorIlinko Vrebac
AutorFilip Tudor https://orcid.org/0000-0001-6386-0444
AutorIvan Vukelić
AutorTamara Braut
Autorova ustanova(Klinički bolnički centar Rijeka)
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za otorinolaringologiju)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Otorinolaringologija
Sažetak (engleski)
Testosterone replacement therapy is becoming more and more popular in men as "anti-aging medicine". Testosterone has beneficial effects on body mass and muscle gain, and much research has examined testosterone in palliative cancer therapy for oncology patients. In addition to direct effects on weight gain, testosterone improves mood and self-confidence, strength, libido, muscle mass, bone density, and cognitive functions and reduces the risk of cardiovascular disease. Lower testosterone levels are found in 65 % of male patients with progressive tumors compared to only 6 % of men in the general population. We hypothesize that perioperative substitution testosterone therapy (PSTT) together with a balanced diet, may be more effective than balanced diet alone in the overall treatment outcome of patients with head and neck squamous cell carcinomas. Therefore, PSTT in combination with a balanced diet should be considered as an additional tool for head and neck carcinoma treatment.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaCritical Reviews in Oncology/Hematology
Brojčani podacivol. 188, 104062
p-ISSN1040-8428
DOIhttps://doi.org/10.1016/j.critrevonc.2023.104062
URN:NBNurn:nbn:hr:184:093127
Datum objave elektroničkog izdanja2023-06-28
URL dokumentahttps://linkinghub.elsevier.com/retrieve/pii/S1040842823001506
Vrsta resursaTekst
Prava pristupaInstitucijski pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2023-08-31 08:25:42